GeneDx announces 27 genomic research abstracts accepted for ASHG 2026

GeneDx said its research will examine broader clinical use of exome and genome sequencing, including autism diagnosis and genomic newborn screening across diverse ancestries. Other studies will explore new disease-associated genes and the economic value of genomic sequencing as a first-line test. Results remain under embargo until their presentations or poster sessions.